Virxsys
Latest round
- Series F
Last raised
- Oct 2005
Total raised
- $30M
Investors
- 1
About Virxsys
VIRxSYS Corporation, a biotechnology company, focuses on the development of gene and vaccine therapies for the treatment of HIV/AIDS, cancer, and genetic diseases.
Who invested in Virxsys
1 investor across 1 round
See all investors in Virxsys
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series F
Oct 11, 2005
Amount
$30M
Investors
Questions about Virxsys
Who invested in Virxsys?
Virxsys has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Virxsys raised?
Virxsys has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Virxsys last raise money?
Virxsys's most recent round on record is a Series F, in Oct 2005.
What does Virxsys do?
VIRxSYS Corporation, a biotechnology company, focuses on the development of gene and vaccine therapies for the treatment of HIV/AIDS, cancer, and genetic diseases.
Where is Virxsys headquartered?
Virxsys is headquartered in Gaithersburg, US.
Which VCs invest in companies like Virxsys?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Virxsys's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series F
Raising like Virxsys? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.